Nuclear Medicine/Radiopharmaceutic Market
1 Introduction to Research & Analysis Reports
1.1 Nuclear Medicine/Radiopharmaceutic Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Nuclear Medicine/Radiopharmaceutic Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Nuclear Medicine/Radiopharmaceutic Overall Market Size
2.1 Global Nuclear Medicine/Radiopharmaceutic Market Size: 2021 VS 2028
2.2 Global Nuclear Medicine/Radiopharmaceutic Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Nuclear Medicine/Radiopharmaceutic Sales: 2017-2028
3 Company Landscape
3.1 Top Nuclear Medicine/Radiopharmaceutic Players in Global Market
3.2 Top Global Nuclear Medicine/Radiopharmaceutic Companies Ranked by Revenue
3.3 Global Nuclear Medicine/Radiopharmaceutic Revenue by Companies
3.4 Global Nuclear Medicine/Radiopharmaceutic Sales by Companies
3.5 Global Nuclear Medicine/Radiopharmaceutic Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Nuclear Medicine/Radiopharmaceutic Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Nuclear Medicine/Radiopharmaceutic Product Type
3.8 Tier 1, Tier 2 and Tier 3 Nuclear Medicine/Radiopharmaceutic Players in Global Market
3.8.1 List of Global Tier 1 Nuclear Medicine/Radiopharmaceutic Companies
3.8.2 List of Global Tier 2 and Tier 3 Nuclear Medicine/Radiopharmaceutic Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Nuclear Medicine/Radiopharmaceutic Market Size Markets, 2021 & 2028
4.1.2 Tc-99
4.1.3 I-123/131
4.1.4 In-111
4.1.5 Xe-133
4.1.6 Th-201
4.1.7 Ga-67
4.1.8 Other
4.2 By Type - Global Nuclear Medicine/Radiopharmaceutic Revenue & Forecasts
4.2.1 By Type - Global Nuclear Medicine/Radiopharmaceutic Revenue, 2017-2022
4.2.2 By Type - Global Nuclear Medicine/Radiopharmaceutic Revenue, 2023-2028
4.2.3 By Type - Global Nuclear Medicine/Radiopharmaceutic Revenue Market Share, 2017-2028
4.3 By Type - Global Nuclear Medicine/Radiopharmaceutic Sales & Forecasts
4.3.1 By Type - Global Nuclear Medicine/Radiopharmaceutic Sales, 2017-2022
4.3.2 By Type - Global Nuclear Medicine/Radiopharmaceutic Sales, 2023-2028
4.3.3 By Type - Global Nuclear Medicine/Radiopharmaceutic Sales Market Share, 2017-2028
4.4 By Type - Global Nuclear Medicine/Radiopharmaceutic Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Nuclear Medicine/Radiopharmaceutic Market Size, 2021 & 2028
5.1.2 Diagnostic
5.1.3 Therapeutic
5.2 By Application - Global Nuclear Medicine/Radiopharmaceutic Revenue & Forecasts
5.2.1 By Application - Global Nuclear Medicine/Radiopharmaceutic Revenue, 2017-2022
5.2.2 By Application - Global Nuclear Medicine/Radiopharmaceutic Revenue, 2023-2028
5.2.3 By Application - Global Nuclear Medicine/Radiopharmaceutic Revenue Market Share, 2017-2028
5.3 By Application - Global Nuclear Medicine/Radiopharmaceutic Sales & Forecasts
5.3.1 By Application - Global Nuclear Medicine/Radiopharmaceutic Sales, 2017-2022
5.3.2 By Application - Global Nuclear Medicine/Radiopharmaceutic Sales, 2023-2028
5.3.3 By Application - Global Nuclear Medicine/Radiopharmaceutic Sales Market Share, 2017-2028
5.4 By Application - Global Nuclear Medicine/Radiopharmaceutic Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Nuclear Medicine/Radiopharmaceutic Market Size, 2021 & 2028
6.2 By Region - Global Nuclear Medicine/Radiopharmaceutic Revenue & Forecasts
6.2.1 By Region - Global Nuclear Medicine/Radiopharmaceutic Revenue, 2017-2022
6.2.2 By Region - Global Nuclear Medicine/Radiopharmaceutic Revenue, 2023-2028
6.2.3 By Region - Global Nuclear Medicine/Radiopharmaceutic Revenue Market Share, 2017-2028
6.3 By Region - Global Nuclear Medicine/Radiopharmaceutic Sales & Forecasts
6.3.1 By Region - Global Nuclear Medicine/Radiopharmaceutic Sales, 2017-2022
6.3.2 By Region - Global Nuclear Medicine/Radiopharmaceutic Sales, 2023-2028
6.3.3 By Region - Global Nuclear Medicine/Radiopharmaceutic Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Nuclear Medicine/Radiopharmaceutic Revenue, 2017-2028
6.4.2 By Country - North America Nuclear Medicine/Radiopharmaceutic Sales, 2017-2028
6.4.3 US Nuclear Medicine/Radiopharmaceutic Market Size, 2017-2028
6.4.4 Canada Nuclear Medicine/Radiopharmaceutic Market Size, 2017-2028
6.4.5 Mexico Nuclear Medicine/Radiopharmaceutic Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Nuclear Medicine/Radiopharmaceutic Revenue, 2017-2028
6.5.2 By Country - Europe Nuclear Medicine/Radiopharmaceutic Sales, 2017-2028
6.5.3 Germany Nuclear Medicine/Radiopharmaceutic Market Size, 2017-2028
6.5.4 France Nuclear Medicine/Radiopharmaceutic Market Size, 2017-2028
6.5.5 U.K. Nuclear Medicine/Radiopharmaceutic Market Size, 2017-2028
6.5.6 Italy Nuclear Medicine/Radiopharmaceutic Market Size, 2017-2028
6.5.7 Russia Nuclear Medicine/Radiopharmaceutic Market Size, 2017-2028
6.5.8 Nordic Countries Nuclear Medicine/Radiopharmaceutic Market Size, 2017-2028
6.5.9 Benelux Nuclear Medicine/Radiopharmaceutic Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Nuclear Medicine/Radiopharmaceutic Revenue, 2017-2028
6.6.2 By Region - Asia Nuclear Medicine/Radiopharmaceutic Sales, 2017-2028
6.6.3 China Nuclear Medicine/Radiopharmaceutic Market Size, 2017-2028
6.6.4 Japan Nuclear Medicine/Radiopharmaceutic Market Size, 2017-2028
6.6.5 South Korea Nuclear Medicine/Radiopharmaceutic Market Size, 2017-2028
6.6.6 Southeast Asia Nuclear Medicine/Radiopharmaceutic Market Size, 2017-2028
6.6.7 India Nuclear Medicine/Radiopharmaceutic Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Nuclear Medicine/Radiopharmaceutic Revenue, 2017-2028
6.7.2 By Country - South America Nuclear Medicine/Radiopharmaceutic Sales, 2017-2028
6.7.3 Brazil Nuclear Medicine/Radiopharmaceutic Market Size, 2017-2028
6.7.4 Argentina Nuclear Medicine/Radiopharmaceutic Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Nuclear Medicine/Radiopharmaceutic Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Nuclear Medicine/Radiopharmaceutic Sales, 2017-2028
6.8.3 Turkey Nuclear Medicine/Radiopharmaceutic Market Size, 2017-2028
6.8.4 Israel Nuclear Medicine/Radiopharmaceutic Market Size, 2017-2028
6.8.5 Saudi Arabia Nuclear Medicine/Radiopharmaceutic Market Size, 2017-2028
6.8.6 UAE Nuclear Medicine/Radiopharmaceutic Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 GE Healthcare
7.1.1 GE Healthcare Corporate Summary
7.1.2 GE Healthcare Business Overview
7.1.3 GE Healthcare Nuclear Medicine/Radiopharmaceutic Major Product Offerings
7.1.4 GE Healthcare Nuclear Medicine/Radiopharmaceutic Sales and Revenue in Global (2017-2022)
7.1.5 GE Healthcare Key News
7.2 Bracco Imaging
7.2.1 Bracco Imaging Corporate Summary
7.2.2 Bracco Imaging Business Overview
7.2.3 Bracco Imaging Nuclear Medicine/Radiopharmaceutic Major Product Offerings
7.2.4 Bracco Imaging Nuclear Medicine/Radiopharmaceutic Sales and Revenue in Global (2017-2022)
7.2.5 Bracco Imaging Key News
7.3 Mallinckrodt
7.3.1 Mallinckrodt Corporate Summary
7.3.2 Mallinckrodt Business Overview
7.3.3 Mallinckrodt Nuclear Medicine/Radiopharmaceutic Major Product Offerings
7.3.4 Mallinckrodt Nuclear Medicine/Radiopharmaceutic Sales and Revenue in Global (2017-2022)
7.3.5 Mallinckrodt Key News
7.4 Lantheus Medical Imaging
7.4.1 Lantheus Medical Imaging Corporate Summary
7.4.2 Lantheus Medical Imaging Business Overview
7.4.3 Lantheus Medical Imaging Nuclear Medicine/Radiopharmaceutic Major Product Offerings
7.4.4 Lantheus Medical Imaging Nuclear Medicine/Radiopharmaceutic Sales and Revenue in Global (2017-2022)
7.4.5 Lantheus Medical Imaging Key News
7.5 Bayer
7.5.1 Bayer Corporate Summary
7.5.2 Bayer Business Overview
7.5.3 Bayer Nuclear Medicine/Radiopharmaceutic Major Product Offerings
7.5.4 Bayer Nuclear Medicine/Radiopharmaceutic Sales and Revenue in Global (2017-2022)
7.5.5 Bayer Key News
7.6 Jubilant Pharma
7.6.1 Jubilant Pharma Corporate Summary
7.6.2 Jubilant Pharma Business Overview
7.6.3 Jubilant Pharma Nuclear Medicine/Radiopharmaceutic Major Product Offerings
7.6.4 Jubilant Pharma Nuclear Medicine/Radiopharmaceutic Sales and Revenue in Global (2017-2022)
7.6.5 Jubilant Pharma Key News
7.7 Nordion
7.7.1 Nordion Corporate Summary
7.7.2 Nordion Business Overview
7.7.3 Nordion Nuclear Medicine/Radiopharmaceutic Major Product Offerings
7.7.4 Nordion Nuclear Medicine/Radiopharmaceutic Sales and Revenue in Global (2017-2022)
7.7.5 Nordion Key News
7.8 Eli Lilly
7.8.1 Eli Lilly Corporate Summary
7.8.2 Eli Lilly Business Overview
7.8.3 Eli Lilly Nuclear Medicine/Radiopharmaceutic Major Product Offerings
7.8.4 Eli Lilly Nuclear Medicine/Radiopharmaceutic Sales and Revenue in Global (2017-2022)
7.8.5 Eli Lilly Key News
7.9 SIEMENS
7.9.1 SIEMENS Corporate Summary
7.9.2 SIEMENS Business Overview
7.9.3 SIEMENS Nuclear Medicine/Radiopharmaceutic Major Product Offerings
7.9.4 SIEMENS Nuclear Medicine/Radiopharmaceutic Sales and Revenue in Global (2017-2022)
7.9.5 SIEMENS Key News
7.10 China Isotope & Radiation
7.10.1 China Isotope & Radiation Corporate Summary
7.10.2 China Isotope & Radiation Business Overview
7.10.3 China Isotope & Radiation Nuclear Medicine/Radiopharmaceutic Major Product Offerings
7.10.4 China Isotope & Radiation Nuclear Medicine/Radiopharmaceutic Sales and Revenue in Global (2017-2022)
7.10.5 China Isotope & Radiation Key News
7.11 Yantai Dongcheng Biochemicals
7.11.1 Yantai Dongcheng Biochemicals Corporate Summary
7.11.2 Yantai Dongcheng Biochemicals Nuclear Medicine/Radiopharmaceutic Business Overview
7.11.3 Yantai Dongcheng Biochemicals Nuclear Medicine/Radiopharmaceutic Major Product Offerings
7.11.4 Yantai Dongcheng Biochemicals Nuclear Medicine/Radiopharmaceutic Sales and Revenue in Global (2017-2022)
7.11.5 Yantai Dongcheng Biochemicals Key News
8 Global Nuclear Medicine/Radiopharmaceutic Production Capacity, Analysis
8.1 Global Nuclear Medicine/Radiopharmaceutic Production Capacity, 2017-2028
8.2 Nuclear Medicine/Radiopharmaceutic Production Capacity of Key Manufacturers in Global Market
8.3 Global Nuclear Medicine/Radiopharmaceutic Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Nuclear Medicine/Radiopharmaceutic Supply Chain Analysis
10.1 Nuclear Medicine/Radiopharmaceutic Industry Value Chain
10.2 Nuclear Medicine/Radiopharmaceutic Upstream Market
10.3 Nuclear Medicine/Radiopharmaceutic Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Nuclear Medicine/Radiopharmaceutic Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
List of Tables
Table 1. Key Players of Nuclear Medicine/Radiopharmaceutic in Global Market
Table 2. Top Nuclear Medicine/Radiopharmaceutic Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Nuclear Medicine/Radiopharmaceutic Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Nuclear Medicine/Radiopharmaceutic Revenue Share by Companies, 2017-2022
Table 5. Global Nuclear Medicine/Radiopharmaceutic Sales by Companies, (Kiloton), 2017-2022
Table 6. Global Nuclear Medicine/Radiopharmaceutic Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Nuclear Medicine/Radiopharmaceutic Price (2017-2022) & (US$/Ton)
Table 8. Global Manufacturers Nuclear Medicine/Radiopharmaceutic Product Type
Table 9. List of Global Tier 1 Nuclear Medicine/Radiopharmaceutic Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Nuclear Medicine/Radiopharmaceutic Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Nuclear Medicine/Radiopharmaceutic Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Nuclear Medicine/Radiopharmaceutic Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Nuclear Medicine/Radiopharmaceutic Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Nuclear Medicine/Radiopharmaceutic Sales (Kiloton), 2017-2022
Table 15. By Type - Global Nuclear Medicine/Radiopharmaceutic Sales (Kiloton), 2023-2028
Table 16. By Application ? Global Nuclear Medicine/Radiopharmaceutic Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Nuclear Medicine/Radiopharmaceutic Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Nuclear Medicine/Radiopharmaceutic Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Nuclear Medicine/Radiopharmaceutic Sales (Kiloton), 2017-2022
Table 20. By Application - Global Nuclear Medicine/Radiopharmaceutic Sales (Kiloton), 2023-2028
Table 21. By Region ? Global Nuclear Medicine/Radiopharmaceutic Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Nuclear Medicine/Radiopharmaceutic Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Nuclear Medicine/Radiopharmaceutic Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Nuclear Medicine/Radiopharmaceutic Sales (Kiloton), 2017-2022
Table 25. By Region - Global Nuclear Medicine/Radiopharmaceutic Sales (Kiloton), 2023-2028
Table 26. By Country - North America Nuclear Medicine/Radiopharmaceutic Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Nuclear Medicine/Radiopharmaceutic Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Nuclear Medicine/Radiopharmaceutic Sales, (Kiloton), 2017-2022
Table 29. By Country - North America Nuclear Medicine/Radiopharmaceutic Sales, (Kiloton), 2023-2028
Table 30. By Country - Europe Nuclear Medicine/Radiopharmaceutic Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Nuclear Medicine/Radiopharmaceutic Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Nuclear Medicine/Radiopharmaceutic Sales, (Kiloton), 2017-2022
Table 33. By Country - Europe Nuclear Medicine/Radiopharmaceutic Sales, (Kiloton), 2023-2028
Table 34. By Region - Asia Nuclear Medicine/Radiopharmaceutic Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Nuclear Medicine/Radiopharmaceutic Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Nuclear Medicine/Radiopharmaceutic Sales, (Kiloton), 2017-2022
Table 37. By Region - Asia Nuclear Medicine/Radiopharmaceutic Sales, (Kiloton), 2023-2028
Table 38. By Country - South America Nuclear Medicine/Radiopharmaceutic Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Nuclear Medicine/Radiopharmaceutic Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Nuclear Medicine/Radiopharmaceutic Sales, (Kiloton), 2017-2022
Table 41. By Country - South America Nuclear Medicine/Radiopharmaceutic Sales, (Kiloton), 2023-2028
Table 42. By Country - Middle East & Africa Nuclear Medicine/Radiopharmaceutic Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Nuclear Medicine/Radiopharmaceutic Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Nuclear Medicine/Radiopharmaceutic Sales, (Kiloton), 2017-2022
Table 45. By Country - Middle East & Africa Nuclear Medicine/Radiopharmaceutic Sales, (Kiloton), 2023-2028
Table 46. GE Healthcare Corporate Summary
Table 47. GE Healthcare Nuclear Medicine/Radiopharmaceutic Product Offerings
Table 48. GE Healthcare Nuclear Medicine/Radiopharmaceutic Sales (Kiloton), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
Table 49. Bracco Imaging Corporate Summary
Table 50. Bracco Imaging Nuclear Medicine/Radiopharmaceutic Product Offerings
Table 51. Bracco Imaging Nuclear Medicine/Radiopharmaceutic Sales (Kiloton), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
Table 52. Mallinckrodt Corporate Summary
Table 53. Mallinckrodt Nuclear Medicine/Radiopharmaceutic Product Offerings
Table 54. Mallinckrodt Nuclear Medicine/Radiopharmaceutic Sales (Kiloton), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
Table 55. Lantheus Medical Imaging Corporate Summary
Table 56. Lantheus Medical Imaging Nuclear Medicine/Radiopharmaceutic Product Offerings
Table 57. Lantheus Medical Imaging Nuclear Medicine/Radiopharmaceutic Sales (Kiloton), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
Table 58. Bayer Corporate Summary
Table 59. Bayer Nuclear Medicine/Radiopharmaceutic Product Offerings
Table 60. Bayer Nuclear Medicine/Radiopharmaceutic Sales (Kiloton), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
Table 61. Jubilant Pharma Corporate Summary
Table 62. Jubilant Pharma Nuclear Medicine/Radiopharmaceutic Product Offerings
Table 63. Jubilant Pharma Nuclear Medicine/Radiopharmaceutic Sales (Kiloton), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
Table 64. Nordion Corporate Summary
Table 65. Nordion Nuclear Medicine/Radiopharmaceutic Product Offerings
Table 66. Nordion Nuclear Medicine/Radiopharmaceutic Sales (Kiloton), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
Table 67. Eli Lilly Corporate Summary
Table 68. Eli Lilly Nuclear Medicine/Radiopharmaceutic Product Offerings
Table 69. Eli Lilly Nuclear Medicine/Radiopharmaceutic Sales (Kiloton), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
Table 70. SIEMENS Corporate Summary
Table 71. SIEMENS Nuclear Medicine/Radiopharmaceutic Product Offerings
Table 72. SIEMENS Nuclear Medicine/Radiopharmaceutic Sales (Kiloton), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
Table 73. China Isotope & Radiation Corporate Summary
Table 74. China Isotope & Radiation Nuclear Medicine/Radiopharmaceutic Product Offerings
Table 75. China Isotope & Radiation Nuclear Medicine/Radiopharmaceutic Sales (Kiloton), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
Table 76. Yantai Dongcheng Biochemicals Corporate Summary
Table 77. Yantai Dongcheng Biochemicals Nuclear Medicine/Radiopharmaceutic Product Offerings
Table 78. Yantai Dongcheng Biochemicals Nuclear Medicine/Radiopharmaceutic Sales (Kiloton), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
Table 79. Nuclear Medicine/Radiopharmaceutic Production Capacity (Kiloton) of Key Manufacturers in Global Market, 2020-2022 (Kiloton)
Table 80. Global Nuclear Medicine/Radiopharmaceutic Capacity Market Share of Key Manufacturers, 2020-2022
Table 81. Global Nuclear Medicine/Radiopharmaceutic Production by Region, 2017-2022 (Kiloton)
Table 82. Global Nuclear Medicine/Radiopharmaceutic Production by Region, 2023-2028 (Kiloton)
Table 83. Nuclear Medicine/Radiopharmaceutic Market Opportunities & Trends in Global Market
Table 84. Nuclear Medicine/Radiopharmaceutic Market Drivers in Global Market
Table 85. Nuclear Medicine/Radiopharmaceutic Market Restraints in Global Market
Table 86. Nuclear Medicine/Radiopharmaceutic Raw Materials
Table 87. Nuclear Medicine/Radiopharmaceutic Raw Materials Suppliers in Global Market
Table 88. Typical Nuclear Medicine/Radiopharmaceutic Downstream
Table 89. Nuclear Medicine/Radiopharmaceutic Downstream Clients in Global Market
Table 90. Nuclear Medicine/Radiopharmaceutic Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Nuclear Medicine/Radiopharmaceutic Segment by Type
Figure 2. Nuclear Medicine/Radiopharmaceutic Segment by Application
Figure 3. Global Nuclear Medicine/Radiopharmaceutic Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Nuclear Medicine/Radiopharmaceutic Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Nuclear Medicine/Radiopharmaceutic Revenue, 2017-2028 (US$, Mn)
Figure 7. Nuclear Medicine/Radiopharmaceutic Sales in Global Market: 2017-2028 (Kiloton)
Figure 8. The Top 3 and 5 Players Market Share by Nuclear Medicine/Radiopharmaceutic Revenue in 2021
Figure 9. By Type - Global Nuclear Medicine/Radiopharmaceutic Sales Market Share, 2017-2028
Figure 10. By Type - Global Nuclear Medicine/Radiopharmaceutic Revenue Market Share, 2017-2028
Figure 11. By Type - Global Nuclear Medicine/Radiopharmaceutic Price (US$/Ton), 2017-2028
Figure 12. By Application - Global Nuclear Medicine/Radiopharmaceutic Sales Market Share, 2017-2028
Figure 13. By Application - Global Nuclear Medicine/Radiopharmaceutic Revenue Market Share, 2017-2028
Figure 14. By Application - Global Nuclear Medicine/Radiopharmaceutic Price (US$/Ton), 2017-2028
Figure 15. By Region - Global Nuclear Medicine/Radiopharmaceutic Sales Market Share, 2017-2028
Figure 16. By Region - Global Nuclear Medicine/Radiopharmaceutic Revenue Market Share, 2017-2028
Figure 17. By Country - North America Nuclear Medicine/Radiopharmaceutic Revenue Market Share, 2017-2028
Figure 18. By Country - North America Nuclear Medicine/Radiopharmaceutic Sales Market Share, 2017-2028
Figure 19. US Nuclear Medicine/Radiopharmaceutic Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Nuclear Medicine/Radiopharmaceutic Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Nuclear Medicine/Radiopharmaceutic Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Nuclear Medicine/Radiopharmaceutic Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Nuclear Medicine/Radiopharmaceutic Sales Market Share, 2017-2028
Figure 24. Germany Nuclear Medicine/Radiopharmaceutic Revenue, (US$, Mn), 2017-2028
Figure 25. France Nuclear Medicine/Radiopharmaceutic Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Nuclear Medicine/Radiopharmaceutic Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Nuclear Medicine/Radiopharmaceutic Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Nuclear Medicine/Radiopharmaceutic Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Nuclear Medicine/Radiopharmaceutic Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Nuclear Medicine/Radiopharmaceutic Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Nuclear Medicine/Radiopharmaceutic Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Nuclear Medicine/Radiopharmaceutic Sales Market Share, 2017-2028
Figure 33. China Nuclear Medicine/Radiopharmaceutic Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Nuclear Medicine/Radiopharmaceutic Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Nuclear Medicine/Radiopharmaceutic Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Nuclear Medicine/Radiopharmaceutic Revenue, (US$, Mn), 2017-2028
Figure 37. India Nuclear Medicine/Radiopharmaceutic Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Nuclear Medicine/Radiopharmaceutic Revenue Market Share, 2017-2028
Figure 39. By Country - South America Nuclear Medicine/Radiopharmaceutic Sales Market Share, 2017-2028
Figure 40. Brazil Nuclear Medicine/Radiopharmaceutic Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Nuclear Medicine/Radiopharmaceutic Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Nuclear Medicine/Radiopharmaceutic Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Nuclear Medicine/Radiopharmaceutic Sales Market Share, 2017-2028
Figure 44. Turkey Nuclear Medicine/Radiopharmaceutic Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Nuclear Medicine/Radiopharmaceutic Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Nuclear Medicine/Radiopharmaceutic Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Nuclear Medicine/Radiopharmaceutic Revenue, (US$, Mn), 2017-2028
Figure 48. Global Nuclear Medicine/Radiopharmaceutic Production Capacity (Kiloton), 2017-2028
Figure 49. The Percentage of Production Nuclear Medicine/Radiopharmaceutic by Region, 2021 VS 2028
Figure 50. Nuclear Medicine/Radiopharmaceutic Industry Value Chain
Figure 51. Marketing Channels
Industry Market Size
